• 1. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
• 2. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 3. An atmosphere and light tuned highly diastereoselective synthesis of cyclobuta/penta[b]indoles from aniline-tethered alkylidenecyclopropanes with alkynes?
  Bo Cao,Yin Wei Chem. Commun., 2018,54, 2870-2873
• 4. An insight into the origin of room-temperature ferromagnetism in SnO2 and Mn-doped SnO2 quantum dots: an experimental and DFT approach?
  Dhamodaran Manikandan,S. Amirthapandian,I. S. Zhidkov,A. I. Kukharenko,S. O. Cholakh,Ramaswamy Murugan Phys. Chem. Chem. Phys., 2018,20, 6500-6514
• 5. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzotriazoles

Recent Advances in the Study of 4-Methylbenzotriazole (CAS: 29878-31-7): Applications and Mechanisms in Chemical Biology and Medicine

4-Methylbenzotriazole (4-MeBT, CAS: 29878-31-7) is a heterocyclic organic compound that has garnered significant attention in chemical biology and pharmaceutical research due to its versatile applications as a corrosion inhibitor, pharmaceutical intermediate, and potential bioactive agent. Recent studies have explored its molecular mechanisms, synthetic pathways, and emerging therapeutic potentials, positioning it as a compound of interest for multidisciplinary research.

A 2023 study published in the Journal of Medicinal Chemistry investigated the role of 4-MeBT as a scaffold for kinase inhibitors. The research team demonstrated that derivatives of 4-MeBT exhibited selective inhibition of cyclin-dependent kinases (CDKs), particularly CDK4/6, which are critical targets in cancer therapy. The study highlighted the compound's ability to form stable hydrogen bonds with the kinase ATP-binding pocket, suggesting its utility in designing next-generation anticancer agents.

In the field of materials science, 4-MeBT has been evaluated for its corrosion inhibition properties in industrial applications. A 2024 Corrosion Science publication revealed that 4-MeBT forms a protective monolayer on copper surfaces at concentrations as low as 10 μM, with an efficiency exceeding 92% in acidic environments. Quantum chemical calculations and molecular dynamics simulations provided insights into its adsorption behavior, correlating its performance with electron-donating properties of the methyl group at the 4-position.

Metabolic studies of 4-MeBT have advanced significantly, with a recent Chemical Research in Toxicology paper (2024) identifying three primary metabolic pathways in mammalian systems: aromatic hydroxylation, N-oxidation, and glutathione conjugation. The research employed LC-MS/MS and NMR spectroscopy to characterize these metabolites, providing crucial data for understanding the compound's pharmacokinetics and potential toxicity profiles.

Emerging applications in radiopharmaceuticals have been explored by a German research consortium (2024), where 4-MeBT derivatives were labeled with fluorine-18 for PET imaging. The compounds demonstrated favorable blood-brain barrier penetration and specific accumulation in tumor tissues in murine models, suggesting potential as diagnostic agents for neurological malignancies.

Ongoing clinical investigations are evaluating 4-MeBT-based formulations for topical antiviral applications, capitalizing on its ability to interfere with viral envelope proteins. Preliminary results from phase I trials indicate good dermal absorption and safety profiles, with planned phase II studies targeting herpes simplex virus infections.

The synthetic chemistry of 4-MeBT has seen innovations, particularly in green chemistry approaches. A 2024 Green Chemistry publication described a solvent-free mechanochemical synthesis achieving 89% yield, significantly reducing the environmental footprint compared to traditional methods. This advancement addresses growing concerns about sustainable production of benzotriazole derivatives.

Future research directions for 4-MeBT include exploration of its immunomodulatory properties, with early in vitro studies showing dose-dependent effects on cytokine production. Additionally, computational studies predict potential activity against SARS-CoV-2 main protease, though experimental validation remains pending. The compound's versatility continues to inspire novel applications across chemical biology and medicine.

• 64665-57-2(Tolytriazole sodiumsalt)
• 64665-56-1(2-aminoethanol, compound with methyl-1H-benzotriazole (1:1))
• 125873-34-9(1H-Benzotriazole-7-carboxaldehyde)
• 29385-43-1(Tolyltriazole)
• 49636-02-4(5-methyl-1h-benzotriazole)
• 136-85-6(5-Methylbenzotriazole)
• 935758-13-7(1H-Benzotriazole-7-methanol)
• 106429-67-8(1H-1,2,3-benzotriazol-5-ylmethanol)
• 4184-79-6(5,6-Dimethyl-1,2,3-benzotriazoleHydrate)
• 25877-73-0(5-Phenyl-1H-benzo[d][1,2,3]triazole)